GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » ROE %

Senomyx (Senomyx) ROE % : -93.35% (As of Jun. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Senomyx ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Senomyx's annualized net income for the quarter that ended in Jun. 2018 was $-14.58 Mil. Senomyx's average Total Stockholders Equity over the quarter that ended in Jun. 2018 was $15.62 Mil. Therefore, Senomyx's annualized ROE % for the quarter that ended in Jun. 2018 was -93.35%.

The historical rank and industry rank for Senomyx's ROE % or its related term are showing as below:

SNMX's ROE % is not ranked *
in the Chemicals industry.
Industry Median: 5.21
* Ranked among companies with meaningful ROE % only.

Senomyx ROE % Historical Data

The historical data trend for Senomyx's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senomyx ROE % Chart

Senomyx Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.41 -56.20 -58.72 -62.26 -7.53

Senomyx Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86.24 -75.54 193.79 -83.61 -93.35

Competitive Comparison of Senomyx's ROE %

For the Specialty Chemicals subindustry, Senomyx's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senomyx's ROE % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Senomyx's ROE % distribution charts can be found below:

* The bar in red indicates where Senomyx's ROE % falls into.



Senomyx ROE % Calculation

Senomyx's annualized ROE % for the fiscal year that ended in Dec. 2017 is calculated as

ROE %=Net Income (A: Dec. 2017 )/( (Total Stockholders Equity (A: Dec. 2016 )+Total Stockholders Equity (A: Dec. 2017 ))/ count )
=-1.263/( (14.802+18.763)/ 2 )
=-1.263/16.7825
=-7.53 %

Senomyx's annualized ROE % for the quarter that ended in Jun. 2018 is calculated as

ROE %=Net Income (Q: Jun. 2018 )/( (Total Stockholders Equity (Q: Mar. 2018 )+Total Stockholders Equity (Q: Jun. 2018 ))/ count )
=-14.584/( (17.187+14.058)/ 2 )
=-14.584/15.6225
=-93.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2018) net income data. ROE % is displayed in the 30-year financial page.


Senomyx  (NAS:SNMX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2018 )
=Net Income/Total Stockholders Equity
=-14.584/15.6225
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-14.584 / 13.14)*(13.14 / 22.8895)*(22.8895 / 15.6225)
=Net Margin %*Asset Turnover*Equity Multiplier
=-110.99 %*0.5741*1.4652
=ROA %*Equity Multiplier
=-63.72 %*1.4652
=-93.35 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2018 )
=Net Income/Total Stockholders Equity
=-14.584/15.6225
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-14.584 / -14.584) * (-14.584 / -14.844) * (-14.844 / 13.14) * (13.14 / 22.8895) * (22.8895 / 15.6225)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.9825 * -112.97 % * 0.5741 * 1.4652
=-93.35 %

Note: The net income data used here is four times the quarterly (Jun. 2018) net income data. The Revenue data used here is four times the quarterly (Jun. 2018) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Senomyx ROE % Related Terms

Thank you for viewing the detailed overview of Senomyx's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Senomyx (Senomyx) Business Description

Traded in Other Exchanges
N/A
Address
Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.
Executives
Christopher J Twomey director 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen director, officer: President & CEO 11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray director 201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal 10 percent owner C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc 10 percent owner 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman director CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger officer: Sr. V.P. Gen. Counsel & Sec. 11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien director SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt officer: SVP, Gen.Counsel & Corp. Sec. C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly director RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell director 525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger director
Beeley Nigel R A officer: VP Discovery ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I 10 percent owner C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019